Professional Independence as the Foundation of Modern Pharmacy Practice: A Comparative Analysis of Deontological Frameworks Across 30 European Jurisdictions

Background: The modern pharmacist is no longer just a person who prepares medicines, but has become an important health care provider involved in public health, including pharmaceutical care, prevention, chronic disease management and digital health. Such a transition requires the need for professional independence, supported by effective regulation. Deontological codes guarantee this independence and duties but variability in legal frameworks across Europe limits consistent innovation in pharmaceutical care. Objectives: The study analyses the deontological framework for pharmacist professional independence across 30 European jurisdictions and evaluates how effectively each national framework protects independence as a precondition for the development of pharmaceutical care, taking into account professional mobility and changes in healthcare system requirements. Methods: A comparative analysis examined deontological codes and professional ethics from 27 EU countries, the UK, Norway, and Switzerland. Data were collected using a 14-criterion protocol on topics like legal status, professional independence, conscientious objection, confidentiality, advertising, inter-professional relations, competition, errors, telepharmacy, digitalization, continuity of care, professional development, salary regulation, pharmaceutical services, and incompatibilities. These criteria were organized into five thematic clusters for comparison. Results: Three regulation models were identified regarding the legal status of deontological codes: (a) incorporation into primary health legislation, (b) delegation to professional bodies to establish binding corporatist codes, and (c) implementation of soft-law professional standards. While all models share an ethical focus, emphasizing patient priority and confidentiality, they differ considerably in terms of legal bindingness, sanctions, and structural safeguards of professional independence—such as pharmacists’ salaries, ownership rights, and incompatibilities. Telepharmacy is governed by different regulatory frameworks, whereas the application of AI in pharmacy practice has not yet been incorporated into existing deontological codes. Conclusions: The current deontological framework affirms professional independence but offers uneven protection; its effectiveness relies more on the legal structure, enforceability, and safeguards than on explicitly enshrined independence. EU-wide harmonization is neither legally feasible nor essential; instead, a shared minimum standard advocated by professional organizations could facilitate European coordination. The digital and AI gap is the most urgent area for deontological updates.